QU

Quinn

YC S22

San Francisco, US · Founded 2022 · 4 employees · 1 known investors

quinnbio.com ↗

Quinn is an AI research service that synthesizes biological, clinical, and competitive evidence from published literature and databases to answer drug development questions for biotech companies. It delivers structured, traceable evidence packages for decisions across target validation, indication prioritization, biomarker strategy, and trial design.

Founders & leadership· Y Combinator alumni (S22)

DG

Daniel Gomariin𝕏Founder/CEO

MS

Michael SnyderCo-founder, PhD, Chair of Genetics at Stanford

Investors · 1

Y

Y Combinator✓ verifiedSan Francisco · $500K